Droxinostat
-
Catalog number9570-5
-
Price176.87 USD
-
Size5 mg
-
-
Alternative_name4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide
-
DescriptionDroxinostat is a selective inhibitor of HDAC3, HDAC6, and HDAC8 with IC₅₀ values of 16.9, 2.47 and 1.46 μM, respectively. Droxinostat sensitizes cells to apoptosis by decreasing c-FLIPL and c-FLIPS expression, reducing cell survival, and inducing apoptosis.
-
CAS Number99873-43-5
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₁H₁₄ClNO₃
-
Molecular Weight243.69
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>40 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA selective inhibitor of HDAC3, HDAC6, and HDAC8
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD01326592
-
PubChem CID568416
-
SMILESCC1=C(C=CC(=C1)Cl)OCCCC(=O)NO
-
InChiInChI=1S/C11H14ClNO3/c1-8-7-9(12)4-5-10(8)16-6-2-3-11(14)13-15/h4-5,7,15H,2-3,6H2,1H3,(H,13,14)
-
InChi KeyJHSXDAWGLCZYSM-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameDroxinostat
-
Alternative nameDroxinostat
-